RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Varney said multiple parties, but the extent of their interest is another question. I still think designing a pivotal trial for RD could be seen by potential partners as daunting. To quote Neuro - "looking for a target event that is relatively uncommon, and would become even less common in the more rigorously monitored climate of a clinical trial, waiting for enough cases to come through to generate enough of a database to establish superiority to naloxone will not be a rapid or inexpensive process."

On the other hand, designing a Sleep Apnea pivotal trial is much easier, it's a bigger indication, with appeal to a broader group of potential partners, not just pain oriented companies. So SA has the potential to be the big payday.